Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Cardiovascular
Analysis Reveals Mass General as a National Leader in Treating Carotid Artery Stenosis
Evaluation of carotid artery disease procedures confirms Massachusetts General Hospital as a regional and national leader in benchmarks related to patient outcomes.
Featured In Radiology
Ultrasound-guided Cryoablation Offers Minimally Invasive Alternative for Treatment of Early-Stage Breast Cancer
Ultrasound-guided cryoablation offers a range of advantages over conventional approaches to treating breast cancer. In October 2023, Massachusetts General Hospital successfully introduced the technique into its clinical practice.
Featured In Neuroscience
Genomic Therapeutics in Action: Antisense Oligonucleotides Interventions Reverses Neurodegeneration
Physician-investigators at Massachusetts General Hospital recently published findings that provide a critical step forward in understanding the mechanisms underlying a host of neurodegenerative diseases.
Featured In Digestive Health
Digital App-based Cognitive Behavioral Therapy Significantly Improves IBS Symptoms
At the American College of Gastroenterology 2023 Scientific Meeting, Mythili Pathipati, MD, presented findings from a real-world study where app-delivered cognitive behavioral therapy resulted in a significant reduction in symptom severity and perceived stress for patients with irritable bowel syndrome.
Featured In Orthopaedics
Multidimensional Imaging Expands Clinical Understanding of Trochlear Dysplasia and Patellar Instability
In this video from Orthopedics Today, sports medicine orthopedic surgeon Miho Tanaka, MD, PhD, describes how three- and four-dimensional imaging technology is advancing clinical understandings of knee conditions such as trochlear dysplasia and patellar instability.
The Latest Oncology Advances
Neoadjuvant Therapy Safe, Effective for Elderly Patients With Pancreatic Ductal Adenocarcinoma
Guoliang Qiao, MD, PhD, Motaz Qadan, MD, PhD, and colleagues demonstrated patients ≥75 years old with pancreatic ductal adenocarcinoma were associated with longer overall and recurrence-free survival if they underwent neoadjuvant chemotherapy instead of upfront surgical resection; postoperative complication rates were similar.
Concurrent Immunosuppressive Therapy With Restart of Checkpoint Inhibitor Reduces Risk of Recurrent Immune-related Enterocolitis
A retrospective study at Massachusetts General Hospital and two other centers found cancer patients who had an immune checkpoint inhibitor restarted after an episode of immune-related enterocolitis had significantly less risk of severe recurrent enterocolitis if they concurrently received infliximab or vedolizumab.
Contributing Physicians
Aditya Bardia, MD, MPH
Director of Precision Medicine, Center for Breast Cancer, Mass General Cancer Center, Founding Director, Molecular and Precision Medicine Metastatic Breast Cancer Clinic, Mass General Cancer Center, Assistant Professor in Medicine, Harvard Medical School
Priscilla K. Brastianos, MD
Director, Central Nervous System Metastasis Center, Mass General Cancer Center, Associate Professor of Medicine, Harvard Medical School
Advances Specialties
OB/GYN
Review: Barriers to Cervical Cancer Prevention in Ukraine
Annekathryn Goodman, MD, gynecologic oncologist and co-director of Women's Global Health at Massachusetts General Hospital, and colleagues have documented a need for Ukraine to expand awareness of and access to cervical cancer screening and human papillomavirus vaccination programs.
Pulmonary and Critical Care
Host Factors Identified That Regulate Latency of Mycobacterium tuberculosis
Ramnik J. Xavier, MD, PhD, Haroon Kalam, PhD, and colleagues have identified the host transcriptome involved in various phenotypic states of Mycobacterium tuberculosis (Mtb) infection of macrophages and have pinpointed MMGT1–GPR156 signaling as a regulator of the lipid droplet formation that helps latent Mtb survive.
Rheumatology, Allergy and Immunology
Medical Grand Rounds: A 50-Year Story of Lyme Arthritis
In a recent Medical Grand Rounds presentation, Allen C. Steere, MD, shared his 50-year journey investigating Lyme arthritis, beginning in the 1970s with his identification and description of the clinical syndrome and leading to many pivotal discoveries throughout his decades of work.
December 5-9, 2023
Conference: San Antonio Breast Cancer Symposium 2023
At the 46th annual San Antonio Breast Cancer Symposium (SABCS), leading faculty from the Mass General Cancer Center will join over 10,000 international clinicians and scientists to contribute their latest advancements in breast cancer research.
December 9-12, 2023
Conference: American Society of Hematology Annual Meeting 2023
The Mass General Cancer Center will present their latest research at the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, CA. In its 65th year, the ASH Annual Meeting & Exposition offers educational meetings and workshops for hematology professionals from around the world.
